2nd Circ. Won't Revive Mirena Injury MDL Against Bayer
By Rachel Graf (October 24, 2017, 3:47 PM EDT) -- The Second Circuit on Tuesday affirmed the dismissal of multidistrict litigation over alleged injuries from Bayer Pharmaceuticals Inc.'s intrauterine device Mirena, saying the lower court properly excluded problematic testimony by the plaintiffs' experts.
The three-judge panel said the witnesses supplied by the women allegedly injured by Mirena offered unaccepted and unsupported theories about "secondary perforation," in which the women were supposedly injured after the device was inserted into the uterus. The lower court correctly determined that witness testimony would be needed to prove causation, and granted summary judgment in Bayer's favor, the panel said.
"In its careful and well-reasoned opinion and...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!